🇺🇸 FDA
Patent

US 11273127

Compositions, methods and uses for thermally stable multi-targeted antigens

granted A61KA61K2039/5252A61K2039/5258

Quick answer

US patent 11273127 (Compositions, methods and uses for thermally stable multi-targeted antigens) held by The Regents of the University of Colorado, a Body Corporate expires Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Mar 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K2039/5252, A61K2039/5258, A61K2039/55505, A61K2039/55572